NCT01054300 - Effects of Once and Twice Daily Dosing Regimen of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-040) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 17, 2010

Primary Completion Date

April 7, 2010

Study Completion Date

April 7, 2010

Conditions

Diabetes Mellitus, Type 2Adult

Interventions

DRUG

Ertugliflozin 2 mg single dose

Ertugliflozin 2 mg dose (two 1 mg strength tablets), administered as a single dose

DRUG

Ertugliflozin 2 mg split into twice daily

Ertugliflozin 1 mg dose (1 mg strength tablet) administered twice daily x 1 day

DRUG

Ertugliflozin 4 mg single dose

Ertugliflozin 4 mg dose (four 1 mg strength tablets), administered as a single dose

DRUG

Ertugliflozin 4 mg split into twice daily

Ertugliflozin 2 mg dose (two 1 mg strength tablets) administered twice daily x 1 day

DRUG

Placebo

Placebo to ertugliflozin administered as a single dose